國立陽明大學醫學系畢業(學士 1994.9 ~ 2001.6)
國立政治大學EMBA(碩士 2019/02 ~ 2021/06)

和信醫院 住院醫師 2001/08 ~ 2005/08

台北市醫師公會會員
中華民國核醫學學會會員
臺灣醫用迴旋加速器學會會員

• YY Huang, JSH Tsung：Alpha-fetoprotein Producing Gastric Cancer：A Case Report. J Biomed Lab Sci, 2002;14:25-28.
• YY Huang, DL You, YM Lin, TCL Soong, VP Chuang, PS Yang: Radionuclide Hepatobiliary Imaging in Evaluation of Reserved Hepatic Function in Patients with Hepatocellular Carcinoma before Transcatheter Arterial Embolization. Ann Nucl Med Sci 2004;17:1-6.
• YY Huang, DL You, BL Yu, MH Tsou：Radionuclide Sentinel Lymph Node Scan and Biopsy in Breast Cancer：The Experience in a Cancer Center. Ann Nucl Med Sci 2004;17:185-190.
• Yu-Yi Huang, Dong-Ling You, Mei-Hwa Tsou, Chia-Chuan Liu, Pei-Ing Lee. Primary Pulmonary Pleomorphic Adenoma with High Uptake of FDG - A Case Report. Eur J Radiology Ex 2007;62:73-76.
• YL Lin, DL You, BL Yu, AY Chuang, NC Shih, MH Tsou, PI Lee, YY Huang. Radiation Safety with Breast Sentinel Lymph Node Lymphoscintigraphy. Ann Nucl Med Sci. 2007;20:15-19.
• Yu-Yi Huang, Dong-Ling You, Mei-Ching Liu, Tran-Der Tan, Pei-Ing Lee, Ming-Yuan Lee. Under performance of Gallium-67 Scan vs. FDG-PET is greater in relapse than in initial staging. Clin Nucl Med 2011;36:867–871.
• Yu-Yi Huang, Pei-Ing Lee, Mei-Ching Liu, Chien-Chih Chen, Kuo-Cheng Huang, Andrew T. Huang. A general cut-off level combined with personalized dynamic change of serum carcinoembryonic antigen can suggest timely use of FDG-PET for early detection of recurrent colorectal cancer. Clin Nucl Med 2015;40:e465-469.
• Yu-Yi Huang, Mao-Chin Hung, Li-Fan Lin, Cheng-Yi Cheng. The Utilization of Nuclear Medicine Studies and the Dilemma in Taiwan: A Brief Report. Ann Nucl Med Mol Imaging 2016;29:166-178.
• Mao-Chin Hung, Yu-Yi Huang, Cheng-Yi Cheng, Li-Fan Lin, Cheng-Han Yang. Nuclear Medicine Practice with National Health Insurance in Taiwan, 2000 ~ 2013. Ann Nucl Med Mol Imaging 2017;30:62-71.
• Chen-Sung Lin, Yu-Yi Huang, Siao-Cian Pan, Chih-Tao Cheng, Chia-Chuan Liu, Chih-Hsun Shih, Hsiang-Ling Ho, Yi-Chen Yeh, Teh-Ying Chou, Ming-Yuan Lee, Yau-Huei Wei. Involvement of increased p53 expression in the decrease of mitochondrial DNA copy number and increase of SUVmax of FDG PET scan in esophageal squamous cell carcinoma. Mitochondrion. 2019;47:54-63.
• Mao-Chin Hung, Yu-Yi Huang. Three Nuclear Medicine diagnostic procedures and breast cancer modality in women. A population-analysis in Taiwan cased upon national health insurance database. Hell J Nucl Med 2019;22(2):111-115.
• Yu-Yi Huang, Pei-Ing Lee, Lun-Wei Chiou, Chu-Yun Chen. Markedly Decrease Hepatic FDG Avidity in two patients with severe hypoalbuminemia. Ann Nucl Med Mol Imaging 2019;32:85-89.
• Li-Yen Chen, Yu-Yi Huang, Pei-Ing Lee, Sheng-Chieh Chan, Ku-Hung Lin, Ting-Juan Lin, Yu-Fen Wei, Ching-Han Hsu, Wen-Sheng Huang, Fang-Yuh Hsuh. Radiation safety assessment of caregivers of thyroid cancer patients treated with 131I in Taiwan. Radiation Physics and Chemistry 172 (2020) 108781.
• Yu-Yi Huang, Ting-Chum Lin, Shih-Han Yang, Lan-Shih Lai, Ling-Man Hung, Ming-Hsin Li, and Kuo-Cheng Huang. [177Lu]Lu-Prostate-Specific Membrane Antigen-617 in a Patient with Metastatic Castration-Resistant Prostate Cancer and Status After Bilateral Nephrectomy. J Nucl Med. 2024 Apr 18:jnumed.124.267533. doi: 10.2967/jnumed.124.267533.
• Chao-Yuan Huang, Chi-Ping Huang, Yu-Yi Huang, Steven Kuan-Hua Huang, Kevin Lu, William Ji-Sien Huang, En Meng, Shu-Pin Huang, Ming-Yang Lee, Frank Chen, See-Tong Pang. Real-world safety and effectiveness of radium-223 in patients with metastatic castration-resistant prostate cancer: Interim analyses of the prospective, observational RAPIT study. Int. J. Cancer. 2024;1–10. DOI: 10.1002/ijc.35040.
• Yu-Yi Huang, Ting-Chum Lin, Shih-Han Yang, Lan-Shih Lai, Ling-Man Hung, Ming-Hsin Li, Ching-Yueh Hsia, Kuo-Cheng Huang. Radiation safety and dialysate analysis in hemodialysis following Lu-177-PSMA-617 therapy: A case report. Radiology Case Reports, 2025;805-809, ISSN 1930-0433, https://doi.org/10.1016/j.radcr.2024.10.084.